Priority Date: 05.07.12 (US 201213507537)

DIAGNOSTIC AND THERAPEUTIC POTENTIAL OF HLA-E MONOSPECIFIC MONOCLONAL IgG ANTIBODIES DIRECTED AGAINST TUMOR CELL SURFACE AND SOLUBLE HLA-E

  • Application ID: EP13813710
  • Status: GRANT OF PATENT INTENDED

Attorney

Employment test 11 - 50 employees
Company dna zbm patents sl
no operation time available
Headquarter in Barcelona and 2 offices
active in Legal Services, IP Consulting, and IP-related Communication Service

Specialization

This EP application has the IPC class A61, C07, and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Kilburn & Strode LLP, Potter Clarkson LLP and 62 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 05.07.2012 - Priority Date (US 201213507537)
  • 09.01.2014 - Publication A2 (WO2014008206)
  • 13.05.2015 - Publication A2 (EP2870179)